Paul Govern Archive — Page 32 of 54

October 3, 2019

Study: personalized decision support affects intensive care

For patients in pediatric intensive care who are at high risk for acute kidney injury (AKI), giving clinicians automated decision support during the electronic order entry process increased the rate of blood testing for AKI by 9%.

October 3, 2019

Diabetes drug study explores cardiovascular risks for patients with kidney disease

An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

October 2, 2019

Research team sorts out drug screen false positive results

Vanderbilt investigators have identified 13 previously unknown drug compounds that cause false positive screenings for amphetamines, buprenorphine (an opioid), cannabinoids and methadone.

September 25, 2019

Study to explore care coordination’s impact on patient outcomes

You Chen, PhD, has been awarded a four-year, $1.5 million research grant to study care coordination patterns and their influence on hospital length of stay and unplanned patient readmission.

September 24, 2019

Treating C. diff: new purpose for an old drug?

An inexpensive generic drug once used to prevent gastrointestinal ulcers in people taking daily NSAIDs protects against C. diff infection in mice.

September 19, 2019

VUMC’s Blume honored by the University of Amsterdam

The University of Amsterdam has awarded the 2019 Spinoza Chair in medicine to Jeffrey Blume, PhD, associate professor of Biostatistics and Biomedical Informatics at VUMC.